Serology Safety Data Sheet (SDS)

Catalogue Number Product Name
20410102 Alphavirus
20350102 Bordetella pertussis
20030102 Brucella
20040102 Chlamydia genus
20460102 Coronavirus SARS-CoV-2 Antibodies
20480102 Coronavirus SARS-CoV-2 Antigen
20220102 Cryptococcal Antigen
20180102 Cytomegalovirus
20420102 Dengue virus
20230102 Entamoeba
20190102 Epstein Barr virus
20430102 Flavivirus
20050102 Helicobacter pylori
20120102 Hepatitis A
20130102 Hepatitis B
20140102 Hepatitis C
20150102 Hepatitis D
20160102 Hepatitis E
20440102 Herpes simplex
20320102 Human Immunodeficiency Virus
20330102 Human T-Lymphotropic Virus
20240102 Hydatid
20170102 Infectious Mononucleosis
20360102 Influenza A and B Antibody
20060102 Legionella Antibody
20070102 Legionella Antigen
20250102 Leptospirosis
20260102 Lyme Disease
20370102 Measles
20380102 Mumps
20080102 Mycoplasma
20450102 Parvovirus
20290102 PoCT Human Immunodeficiency Virus
20300102 PoCT Influenza A and B Antigen
20310102 PoCT RSV Antigen
20390102 Q Fever
20090102 QuantiFERON-TB
20100102 Rickettsia
20010102 Rubella
20270102 Schistosomiasis
20110102 Streptococcus
20280102 Strongyloides
20020102 Syphilis
20200102 Toxoplasma
20400102 Varicella zoster

Recommended use: Quality Assurance/Proficiency Testing programs. Not to be used in the treatment and diagnosis of patients.

Hazard Identification

Chemical hazard: Not applicable

Environmental hazard: Not applicable

Health hazard: Biological Substance Category B

No known test method can offer complete assurance that products derived from inactivated microorganisms and/or human sources will not transmit infection. All proficiency testing materials supplied by RCPAQAP must be handled appropriately and with care. The participant is responsible for the safe handling, storage and disposal of RCPAQAP proficiency testing materials in such a way that ensures that the proficiency testing materials will not cause any harm to any person.

The participant understands and acknowledges that, given the nature and characteristics of RCPAQAP proficiency testing materials;

  • laboratory staff should be trained in the handling of infectious materials.
  • proficiency testing materials should be processed in a laboratory environment as identified by the relevant legislative requirements.
  • they are aware of all matters that concern the safe handling, storage and disposal of proficiency testing materials.
  • they have the facilities and processes required for the safe handling, storage and disposal of proficiency testing materials.
  • that they follow Standard Safety Precautions when handling potentially infectious materials.
  • they utilise Personal Protective Equipment (PPE) as identified by the relevant legislative requirements for the routine handling of potentially infectious materials.

Composition and Information on Ingredients

Products contain the below components:

CAS# Component Percentage
Not Applicable Human fluids and tissue 0–100%
Not Applicable Culture material (see section 9) 0–100%

First-aid Measures

If accidental contact with material occurs laboratory staff should follow appropriate first aid procedures for exposure to an equivalent clinical specimen. Following exposure, medical advice should be sought. If accidental spillage occurs, follow routine procedures for clean-up of potentially biohazardous materials.

Firefighting Measures

Not applicable, not flammable.

Accidental Release Measures

Personal protective equipment such as gloves, gown and protective eyewear should be used before cleaning any spills. Dispose any sharps in a safe disposal system. Clean the area with absorbent paper and clean excess with suitable disinfectant (such as bleach or 70% alcohol).

Handling and Storage

On arrival, samples should be stored as per instructions on each sample kit. Samples have been shown to be stable when transported at ambient temperature.

Samples should be re-constituted or prepared according to Survey Instructions provided.

Exposure Controls and Personal Protection

Samples are only intended for processing in a clinical laboratory facility and should be handled in the same manner as routine patient samples using universal precautions and appropriate personal protective equipment. Biosafety Level 2 precautions at a minimum should be used.

Physical and Chemical Properties

Whole blood:

red and odourless, pH neutral Serum/plasma: straw colour and odourless, pH neutral Urine: straw colour and odourless, pH neutral

Lyophilised serum/plasma – straw colour powder, pH neutral

Cerebrospinal Fluid (CSF) – clear to straw colour and odourless, pH neutral

Inactivated culture materials – clear to pink and odourless, pH neutral

Culture materials (not inactivated; legionella antigen and cryptococcus antigen programs only) – clear to pink and odourless, pH neutral

Stability and Reactivity

This material is stable under normal temperatures and pressures, is non-corrosive, and polymerization will not occur.

Conditions to avoid: Avoid excess heat.

Toxicological Information

These samples are potentially infectious and may be positive for hepatitis B, hepatitis C virus, human immunodeficiency virus (anti-HIV-1/HIV-2) or other infectious diseases.

Ecological Information

Same biodegradability as human blood, urine and other bodily fluids.

Disposal Information

Dispose as clinical waste in suitably identified containers using a registered clinical waste disposal contractor (same as for patient samples).

Transport Information

Proper Shipping Name: Biological Substance Category B

UN Number: UN3373

Hazard Class/Packing Group: Category B Labels Required: UN3373

IATA Packaging Requirements: IATA compliant to PI 650 requirements

Regulatory Information

Not Applicable.

Other Information

Reviewed annually as part of the RCPAQAP compliance with ISO/IEC 17043.

The information provided in this document is believed to be accurate and represents the best information currently available to us. The RCPAQAP make no warranty or merchantability or any other warranty, express or implied, with respect to such information, and we assume no liability from its use. Users should make their own investigations to determine the suitability of the information for their particular purpose. In no event shall the RCPAQAP be liable for any claims, losses or damages of any third party or for lost profits or any special, indirect, incidental, consequential or exemplary damages, arising from the use of this product or the information contained in the Material Safety Data Sheet.